{"nct_id":"NCT05144841","title":"A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-01-08","start_date_type":"ACTUAL","primary_completion_date":"2026-01-09","primary_completion_date_type":"ESTIMATED","completion_date":"2026-01-09","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}